MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucose-stimulated insulin secretion

Biochemical and Biophysical Research Communications

Volumn 426, Issue 2, 2012, Pages 266-272

  Bagge, Annika ^a   Clausen, Trine R ^b   Larsen, Sylvester ^a   Ladefoged, Mette ^b   Rosenstierne, Maiken W ^a,d   Larsen, Louise ^c   Vang, Ole ^a   Nielsen, Jens H ^c   Dalgaard, Louise T ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Beta cell; Beta cell dysfunction; Glucose toxicity; Islets of Langerhans; MicroRNA; MicroRNA 29a

Indexed keywords

GLUCOSE; INSULIN; MICRORNA 29;

ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL SIZE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; INSULIN RELEASE; LANGERHANS CELL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL SIZE; GLUCOSE; GLUCOSE INTOLERANCE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MICRORNAS; RATS; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 84866373881     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.082     Document Type: Article

References (34)

1. Chang-Chen K.J., Mullur R., Bernal-Mizrachi E. Beta-cell failure as a complication of diabetes. Rev. Endocr. Metab. Disord. 2008, 9:329-343.
2. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
3. Anello M., Lupi R., Spampinato D., Piro S., Masini M., Boggi U., Del P.S., Rabuazzo A.M., Purrello F., Marchetti P. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetolog 2005, 48:282-289.
4. Maechler P., Li N., Casimir M., Vetterli L., Frigerio F., Brun T. Role of mitochondria in beta-cell function and dysfunction. Adv. Exp. Med. Biol. 2010, 654:193-216.
5. Alonso L.C., Yokoe T., Zhang P., Scott D.K., Kim S.K., O'Donnell C.P., Garcia-Ocana A. Glucose infusion in mice: a new model to induce beta-cell replication. Diabetes 2007, 56:1792-1801.
6. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
7. Rana T.M. Illuminating the silence: understanding the structure and function of small RNAs. Nat. Rev. Mol. Cell Biol. 2007, 8:23-36.
8. Song L., Tuan R.S. MicroRNAs and cell differentiation in mammalian development birth defects. Res. C. Embryo. Today 2006, 78:140-149.
9. Plaisance V., Abderrahmani A., Perret-Menoud V., Jacquemin P., Lemaigre F., Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 2006, 281:26932-26942.
10. Baroukh N., Ravier M.A., Loder M.K., Hill E.V., Bounacer A., Scharfmann R., Rutter G.A., Van Obberghen E. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J. Biol. Chem. 2007, 282:19575-19588.
11. Lovis P., Gattesco S., Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem. 2008, 389:305-312.
12. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X.S., MacDonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
13. Poy M.N., Hausser J., Trajkovski M., Braun M., Collins S., Rorsman P., Zavolan M., Stoffel M. miR-375 maintains normal pancreatic a- and b-cell mass. Proc. Natl. Acad. Sci. USA 2009.
14. Fred R.G., Bang-Berthelsen C.H., Mandrup-Poulsen T., Grunnet L.G., Welsh N. High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression. PLoS One 2010, 5:e10843.
15. Tang X., Muniappan L., Tang G., Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA 2009, 15:287-293.
16. Lovis P., Roggli E., Laybutt D.R., Gattesco S., Yang J.Y., Widmann C., Abderrahmani A., Regazzi R. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 2008, 57:2728-2736.
17. He A., Zhu L., Gupta N., Chang Y., Fang F. Over-expression of miR-29, highly upregulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol. Endocrinol. 2007.
18. Herrera B.M., Lockstone H.E., Taylor J.M., Wills Q.F., Kaisaki P.J., Barrett A., Camps C., Fernandez C., Ragoussis J., Gauguier D., McCarthy M.I., Lindgren C.M. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 diabetes. BMC Med. Genomics 2009, 2:54.
19. Pandey A.K., Verma G., Vig S., Srivastava S., Srivastava A.K., Datta M. miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells. Mol. Cell Endocrinol. 2011, 332:125-133.
20. Dalgaard L.T., Thams P., Gaarn L.W., Jensen J., Lee Y.C., Nielsen J.H. Suppression of FAT/CD36 mRNA by human growth hormone in pancreatic beta-cells. Biochem. Biophys. Res. Commun. 2011, 410:345-350.
21. Jensen J., Galsgaard E.D., Karlsen A.E., Lee Y.C., Nielsen J.H. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production. J. Endocrinol. 2005, 187:25-36.
22. Dalgaard L.T., Roeske-Nielsen A., Månsson J.E., Buschard K. Sulfatide glycolipid protects insulin-producing cells against cytokine-induced apoptosis, a possible role in diabetes. Diabetes Metab. Res. Rev. 2010, 26:631-638.
23. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
24. Ravnskjaer K., Boergesen M., Dalgaard L.T., Mandrup S. Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J. Mol. Endocrinol. 2006, 36:289-299.
25. Abramoff M.D., Magalhaes P.J., Ram S.J. Image processing with image. J. Biophoton. Int. 2004, 11:36-42.
26. Larsen L., Rosenstierne M.W., Gaarn L.W., Bagge A., Pedersen L., Dahmcke C.M., Nielsen J.H., Dalgaard L.T. Expression and localization of microRNAs in perinatal rat pancreas role of miR-21 in regulation of cholesterol metabolism. PLoS One 2011, 6:e25997.
27. Chick W.L., Like A.A. Studies in the diabetic mutant mouse. 3. Physiological factors associated with alterations in beta cell proliferation. Diabetolog 1970, 6:243-251.
28. Boucher A., Lu D., Burgess S.C., Telemaque-Potts S., Jensen M.V., Mulder H., Wang M.Y., Unger R.H., Sherry A.D., Newgard C.B. Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J. Biol. Chem. 2004, 279:27263-27271.
29. E. Roggli, S. Gattesco, D. Caille, C. Briet, C. Boitard, P. Meda, R. Regazzi, Changes in MicroRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice, Diabetes 2012.
30. Poitout V., Robertson R.P. Glucolipotoxicity fuel excess and beta-cell dysfunction. Endocr. Rev. 2008, 29:351-366.
31. Krauss S., Zhang C.Y., Scorrano L., Dalgaard L.T., St-Pierre J., Grey S.T., Lowell B.B. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic b-cell dysfunction. J. Clin. Invest. 2003, 112:1831-1842.
32. Pullen T.J., da Silva Xavier G., Kelsey G., Rutter G.A. miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1). Mol. Cell Biol. 2011, 31:3182-3194.
33. Scatena R. Mitochondria cancer: a growing role in apoptosis cancer cell metabolism and dedifferentiation. Adv. Exp. Med. Biol. 2012, 942:287-308.
34. Kong L., Zhu J., Han W., Jiang X., Xu M., Zhao Y., Dong Q., Pang Z., Guan Q., Gao L., Zhao J., Zhao L. Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol. 2010.